163 related articles for article (PubMed ID: 31282757)
1. Correlation Between
Su H
Nutr Cancer; 2019; 71(7):1055-1060. PubMed ID: 31282757
[TBL] [Abstract][Full Text] [Related]
2. Correlation between Methylenetetrahydrofolate Reductase Polymorphisms and Hepatocellular Carcinoma: A Meta-Analysis.
Su H; Zhang G
Ann Nutr Metab; 2019; 74(3):251-256. PubMed ID: 30917367
[TBL] [Abstract][Full Text] [Related]
3. Correlation between MTHFR polymorphisms and glaucoma: A meta-analysis.
Zhang L; Chen B
Mol Genet Genomic Med; 2019 Apr; 7(4):e00538. PubMed ID: 30851082
[TBL] [Abstract][Full Text] [Related]
4. Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects.
Zhang S; Jiang J; Tang W; Liu L
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32010931
[TBL] [Abstract][Full Text] [Related]
5. Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk: An update meta-analysis and trial sequential analysis.
Wang B; Ma M; Guo X; Yan Y; Li L
Medicine (Baltimore); 2021 Oct; 100(41):e27527. PubMed ID: 34731145
[TBL] [Abstract][Full Text] [Related]
6. The MTHFR polymorphism affect the susceptibility of HCC and the prognosis of HCC liver transplantation.
Wang C; Xie H; Lu D; Ling Q; Jin P; Li H; Zhuang R; Xu X; Zheng S
Clin Transl Oncol; 2018 Apr; 20(4):448-456. PubMed ID: 29185200
[TBL] [Abstract][Full Text] [Related]
7. Association between methylenetetrahydrofolate reductase tagging polymorphisms and susceptibility of hepatocellular carcinoma: a case-control study.
Zhang S; Lin J; Jiang J; Chen Y; Tang W; Liu L
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31694048
[TBL] [Abstract][Full Text] [Related]
8. The roles of
Xu A; Wang W; Jiang X
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30333252
[No Abstract] [Full Text] [Related]
9. Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk in Chinese population.
Qi X; Sun X; Xu J; Wang Z; Zhang J; Peng Z
Tumour Biol; 2014 Mar; 35(3):1757-62. PubMed ID: 24385382
[TBL] [Abstract][Full Text] [Related]
10. Correlations between methylenetetrahydrofolate reductase gene polymorphisms and venous thromboembolism: A meta-analysis of 99 genetic association studies.
Zeng J; Zeng Q
Eur J Prev Cardiol; 2019 Jan; 26(2):120-134. PubMed ID: 30466296
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of MTHFR C677T and A1298C gene polymorphisms: association with the risk of hepatocellular carcinoma.
Qi YH; Yao LP; Cui GB; Liang J; Shao QJ; Yan LF; Du P
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):172-80. PubMed ID: 24316043
[TBL] [Abstract][Full Text] [Related]
12. Significant association between MTHFR C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Sun H; Han B; Zhai H; Cheng X; Ma K
Tumour Biol; 2014 Jan; 35(1):189-93. PubMed ID: 24132589
[TBL] [Abstract][Full Text] [Related]
13. Significant association between the MTHFR A1298C polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Chang W; Meng Q; Liu JH; Wu LX; Chen Y; Chen SD
Genet Mol Res; 2015 Dec; 14(4):15972-80. PubMed ID: 26662389
[TBL] [Abstract][Full Text] [Related]
14. The association between MTHFR gene polymorphisms and hepatocellular carcinoma risk: a meta-analysis.
Qin X; Peng Q; Chen Z; Deng Y; Huang S; Xu J; Li H; Li S; Zhao J
PLoS One; 2013; 8(2):e56070. PubMed ID: 23457501
[TBL] [Abstract][Full Text] [Related]
15. Associations of methylenetetrahydrofolate reductase gene (MTHFR) rs1801131 and rs1801133 polymorphisms with susceptibility to vitiligo: A meta-analysis.
Zhang HZ; Wu JH; Huang Q; Yang Q; Sima Q; Chen KY; Li ZR; He GH
J Cosmet Dermatol; 2021 Jul; 20(7):2359-2368. PubMed ID: 33219596
[TBL] [Abstract][Full Text] [Related]
16. Methylenetetrahydrofolate Reductase Gene rs1801133 and rs1801131 Polymorphisms and Essential Hypertension Risk: A Comprehensive Analysis.
Fan Y; Wu L; Zhuang W
Cardiovasc Ther; 2022; 2022():2144443. PubMed ID: 35284002
[TBL] [Abstract][Full Text] [Related]
17. Methylene tetrahydrofolate reductase (MTHFR) and vascular endothelial growth factor (VEGF) polymorphisms in Brazilian patients with Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC).
Carvalho SCR; Vasconcelos LRS; Fonseca LD; Carmo RF; Tomitão MT; Aroucha DCBL; Pereira LMMB; Stefano JT; Ribeiro-Júnior U; Oliveira CP; Carrilho FJ
Clinics (Sao Paulo); 2021; 76():e2881. PubMed ID: 34644732
[TBL] [Abstract][Full Text] [Related]
18. Correlation between
Huang Z; Guo X; Zhang G; Liang L; Nong B
Int J Biol Markers; 2019 Jun; 34(2):117-122. PubMed ID: 30852978
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer.
Xiong Y; Bian C; Lin X; Wang X; Xu K; Zhao X
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32639550
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of the relationship between MTHFR gene A1298C polymorphism and the risk of adult stroke.
Zhang MJ; Hu ZC; Yin YW; Li BH; Liu Y; Liao SQ; Gao CY; Li JC; Zhang LL
Cerebrovasc Dis; 2014; 38(6):425-32. PubMed ID: 25472665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
